共 17 条
Protective Effect of Val129-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease
被引:26
|作者:
Fernandez-Borges, Natalia
[1
]
Carlos Espinosa, Juan
[1
]
Marin-Moreno, Alba
[1
]
Aguilar-Calvo, Patricia
[1
]
Asante, Emmanuel A.
[2
]
Kitamoto, Tetsuyuki
[3
]
Mohri, Shirou
[3
]
Andreoletti, Olivier
[4
]
Maria Torres, Juan
[1
]
机构:
[1] Inst Nacl Invest & Tecnol Agr & Alimentaria CISA, Ctr Invest Sanidad Anim, Madrid, Spain
[2] UCL, Inst Neurol, MRC Prion Unit, Dept Neurodegenerat Dis, London, England
[3] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan
[4] Ecole Natl Vet Toulouse, Interact Hotes Agents Pathogenes, UMR INRA ENVT 1225, Toulouse, France
关键词:
HUMAN PRION PROTEIN;
TRANSGENIC MICE;
BLOOD-TRANSFUSION;
MOLECULAR-BASIS;
TISSUE SAMPLES;
BSE AGENT;
SCRAPIE;
CJD;
TRANSMISSION;
SHEEP;
D O I:
10.3201/eid2309.161948
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Bovine spongiform encephalopathy (BSE) is the only known zoonotic prion that causes variant Creutzfeldt-Jakob disease (vCJD) in humans. The major risk determinant for this disease is the polymorphic codon 129 of the human prion protein (Hu-PrP), where either methionine (Met(129)) or valine (Val(129)) can be encoded. To date, all clinical and neuropathologically confirmed vCJD cases have been Met(129) homozygous, with the exception of 1 recently reported Met/Val heterozygous case. Here, we found that transgenic mice homozygous for Val(129) Hu-PrP show severely restricted propagation of the BSE prion strain, but this constraint can be partially overcome by adaptation of the BSE agent to the Met(129) Hu-PrP. In addition, the transmission of vCJD to transgenic mice homozygous for Val(129) Hu-PrP resulted in a prion with distinct strain features. These observations may indicate increased risk for vCJD secondary transmission in Val(129) Hu-PrP-positive humans with the emergence of new strain features.
引用
收藏
页码:1522 / 1530
页数:9
相关论文